Drugs / Jia-Wei-Xiao-Yao-San
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT04785261 | Mar 2021 → May 2022 | dry eye syndrome | China Medical University Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT04111341 | May 2016 → Oct 2017 | Sjogren syndrome | Chung Shan Medical University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03838952 | Feb → Dec 2019 | Alzheimer disease | Taipei Veterans General Hospital, Taiwan | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jia-Wei-Xiao-Yao-San | “Ligustilide and ferulic acid, which own significant anti-inflammatory effects, are the effective ingredients of Jia-Wei-Xiao-Yao-San (JWXYS).” NCT04785261 ↗2“Each pack: Jia Wei Xiao Yao San granule(5 gm), Gou Teng granule (1.1 gm),and Ba Ji Tian (1.1 gm), 2 times per day for 12 weeks.” NCT03838952 ↗ “TCM Gan-Lu-Yin 6g in the morning TCM Jia-Wei-Xiao-Yao-San, Ye-Jiao-Teng, Suan-Zao-Ren 8g in the evening for 12 weeks” NCT04111341 ↗ |
| Known as | JWXYS | “Ligustilide and ferulic acid, which own significant anti-inflammatory effects, are the effective ingredients of Jia-Wei-Xiao-Yao-San (JWXYS).” NCT04785261 ↗ |